FOXO3 and idiopathic pulmonary fibrosis: Specifically, the Misharin group3(Fig. 1A, B) documented a noticeable decline in FOXO3 expression in tandem with a surge in USP18 levels within their curated IPF dataset (Fig. 1A, B).